All
Results: 12805-12816 of 82127

Valmet Oyj's Interim Review January 1 - March 31, 2026: Strategy execution progressed in the first quarter, while sales mix impacted the results

CARB-X awards funding to AdJane to advance its nOMV platform-derived vaccine for the prevention of gonorrhea




